Cassava for Alzheimer's Disease
- 50-87 years old
- Diagnosed with mild-to-moderate Alzheimer's disease
Okanagan Clinical Trials is inviting volunteers with mild-to-moderate Alzheimer’s disease (AD) to take part in a new research study of an investigational medication for this indication. Men and women between the ages of 50 to 87 years may be eligible to participate. All study-related care and investigational medication will be provided at no cost, and you may be compensated for your time and travel.